Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 12:31 PM ET

Date/Time Source News Release
10/24/2022 08:00 AM EDT Business Wire PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code
08/12/2022 08:30 AM EDT Business Wire PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
05/16/2022 06:00 AM EDT Business Wire PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab
05/16/2022 06:00 AM EDT Business Wire PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
04/07/2022 04:00 PM EDT Business Wire PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference
04/04/2022 08:00 AM EDT Business Wire PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
03/24/2022 04:00 PM EDT Business Wire PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
03/08/2022 08:00 AM EST Business Wire PhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Update
02/24/2022 04:00 PM EST Business Wire PhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care Conference
02/10/2022 08:00 AM EST Business Wire PhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific Session
Page

Additional News

As of June 4, 2025 • 12:31 PM ET

Date/Time Source News Release
10/24/2022 08:59 AM EDT SeekingAlpha PhaseBio announces Chapter 11 filing; plans to sell lead asset
09/28/2022 12:58 PM EDT SeekingAlpha PhaseBio sinks ~67% after getting transfer notice for lead drug bentracimab's business
08/12/2022 11:55 AM EDT SeekingAlpha PhaseBio Pharmaceuticals (PHAS) Investor Presentation - Slideshow
08/12/2022 09:45 AM EDT Zacks PhaseBio Pharmaceuticals (PHAS) Reports Q2 Loss, Lags Revenue Estimates
08/12/2022 08:41 AM EDT SeekingAlpha PhaseBio Pharmaceuticals GAAP EPS of -$0.34 misses by $0.03, revenue of $0.21M misses by $0.29M
08/10/2022 05:25 PM EDT Zacks ITeos Therapeutics, Inc. (ITOS) Q2 Earnings and Revenues Lag Estimates
08/08/2022 08:25 AM EDT Zacks UniQure (QURE) Reports Q2 Loss, Lags Revenue Estimates
05/23/2022 03:59 PM EDT SeekingAlpha Liquidia slumps as United, MannKind get FDA nod for rival therapy
05/16/2022 07:15 AM EDT Zacks PhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimates
05/16/2022 06:50 AM EDT SeekingAlpha PhaseBio to seek FDA approval for clotting agent in 4Q 2022
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.